BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND LDH AND Prognosis
55 results:

  • 1. 3-NAntC: A Potent Crotoxin B-Derived Peptide against the Triple-Negative MDA-MB-231 breast cancer Cell Line.
    Bezerra P; Motti EF
    Molecules; 2024 Apr; 29(7):. PubMed ID: 38611925
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary thyroid lymphoma: a case series.
    Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
    J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Actinomycin D synergizes with Doxorubicin in triple-negative breast cancer by inducing P53-dependent cell apoptosis.
    Yang H; Li S; Li W; Yang Y; Zhang Y; Zhang S; Hao Y; Cao W; Xu F; Wang H; Du G; Wang J
    Carcinogenesis; 2024 Apr; 45(4):262-273. PubMed ID: 37997385
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Incidence, survival, and associated factors estimation in osteosarcoma patients with lung metastasis: a single-center experience of 11 years in Tianjin, China.
    Zhang C; Wu H; Xu G; Xu Y; Ma W; Li Z; Zhang J
    BMC Cancer; 2023 Jun; 23(1):506. PubMed ID: 37271825
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical outcomes and biomarkers of phyllodes tumors of the breast: A single-center retrospective study.
    Chen K; Xu J; Wang W; Jiang R; Zhang H; Wang X; Cao J; Fang M
    Cancer Med; 2023 May; 12(10):11363-11374. PubMed ID: 37081723
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. TG2 as a novel breast cancer prognostic marker promotes cell proliferation and glycolysis by activating the MEK/ERK/ldh pathway.
    Xu D; Xu N; Sun L; Yang Z; He M; Li Y
    BMC Cancer; 2022 Dec; 22(1):1267. PubMed ID: 36471278
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. KCNQ1OT1 sponges miR-34a to promote malignant progression of malignant melanoma via upregulation of the STAT3/PD-L1 axis.
    Wang X; Ren Z; Xu Y; Gao X; Huang H; Zhu F
    Environ Toxicol; 2023 Feb; 38(2):368-380. PubMed ID: 36399467
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis.
    Giatromanolaki A; Gkegka AG; Pouliliou S; Biziota E; Kakolyris S; Koukourakis M
    Breast Cancer Res Treat; 2022 Jul; 194(1):13-23. PubMed ID: 35482128
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. FTY720 in resistant human epidermal growth factor receptor 2-positive breast cancer.
    Chung WP; Huang WL; Liao WA; Hung CH; Chiang CW; Cheung CHA; Su WC
    Sci Rep; 2022 Jan; 12(1):241. PubMed ID: 34997132
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic Value of Combined Lactate Dehydrogenase, C-Reactive Protein, cancer Antigen 153 and cancer Antigen 125 in Metastatic breast cancer.
    Ma YY; Wang H; Zhao WD; Li YF; Wang JJ; Chen XY; Huang YQ; Wang WJ; Wang Y; Sun SC
    Cancer Control; 2022; 29():10732748211053150. PubMed ID: 34989251
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. High score of ldh plus dNLR predicts poor survival in patients with HER2-positive advanced breast cancer treated with trastuzumab emtansine.
    Li L; Ai L; Jia L; Zhang L; Lei B; Zhang Q
    BMC Cancer; 2022 Jan; 22(1):29. PubMed ID: 34980025
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A Novel Systematic Oxidative Stress Score Predicts the prognosis of Patients with Operable breast cancer.
    Zhang K; Ping L; Du T; Wang Y; Sun Y; Liang G; Wang X; Xie X; Wei W; Xiao X; Tang J
    Oxid Med Cell Longev; 2021; 2021():9441896. PubMed ID: 34659642
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis.
    Lang M; Feng Y; Meng X; Zhao J; Song Z; Qian Z; Qiu L; Zhou S; Liu X; Li L; Yang H; Song Y; Li W; Zhang H
    Hematol Oncol; 2023 Apr; 41(2):239-247. PubMed ID: 34564882
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Changes in Lactate Production, Lactate Dehydrogenase Genes Expression and DNA Methylation in Response to Tamoxifen Resistance Development in MCF-7 Cell Line.
    Hamadneh L; Al-Lakkis L; Alhusban AA; Tarawneh S; Abu-Irmaileh B; Albustanji S; Al-Bawab AQ
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34069745
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis.
    Arundhathi JRD; Mathur SR; Gogia A; Deo SVS; Mohapatra P; Prasad CP
    Mol Biol Rep; 2021 May; 48(5):4733-4745. PubMed ID: 34047880
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Machine learning to predict the cancer-specific mortality of patients with primary non-metastatic invasive breast cancer.
    Zhou CM; Xue Q; Wang Y; Tong J; Ji M; Yang JJ
    Surg Today; 2021 May; 51(5):756-763. PubMed ID: 33104877
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism.
    Ruhnau J; Parczyk J; Danker K; Eickholt B; Klein A
    BMC Cancer; 2020 Jul; 20(1):617. PubMed ID: 32615946
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Lactate concentration in breast cancer using advanced magnetic resonance spectroscopy.
    Cheung SM; Husain E; Masannat Y; Miller ID; Wahle K; Heys SD; He J
    Br J Cancer; 2020 Jul; 123(2):261-267. PubMed ID: 32424149
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Clinicopathological features of myeloid sarcoma and DLBCL in the breast: a comparative study].
    Chen DB; Zhang H; Kong FZ; Jiang Q; Fang XZ; Shen DH; Kan X
    Zhonghua Bing Li Xue Za Zhi; 2020 Mar; 49(3):250-255. PubMed ID: 32187897
    [No Abstract]    [Full Text] [Related]  

  • 20. Diagnostic and prognostic value of the cancer-testis antigen lactate dehydrogenase C4 in breast cancer.
    Cui Z; Chen Y; Hu M; Lin Y; Zhang S; Kong L; Chen Y
    Clin Chim Acta; 2020 Apr; 503():203-209. PubMed ID: 31794764
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.